Valuation: Azenta, Inc.

Market Cap 1.78B 1.6B 1.48B 1.34B 2.5B 170B 2.53B 17.65B 7.03B 88.71B 6.68B 6.54B 282B P/E 2026 *
-11.3x
P/E 2027 * 188x
Enterprise Value 1.78B 1.6B 1.48B 1.34B 2.5B 170B 2.53B 17.65B 7.03B 88.71B 6.68B 6.54B 282B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.78x
Free-Float
75.47%
Yield 2026 *
-
Yield 2027 * -
1 day+3.97%
1 week+10.53%
Current month+16.45%
1 month+18.63%
3 months+40.44%
6 months+67.62%
Current year+22.16%
1 week 35.21
Extreme 35.21
41.26
1 month 33.03
Extreme 33.03
46.41
Current year 15.93
Extreme 15.93
46.41
1 year 15.93
Extreme 15.93
46.41
3 years 15.93
Extreme 15.93
69.16
5 years 15.93
Extreme 15.93
124.79
10 years 12.71
Extreme 12.71
124.79
Manager TitleAgeSince
Chief Executive Officer 66 2026-08-21
Director of Finance/CFO 49 2024-11-30
Chief Tech/Sci/R&D Officer - 2017-06-30
Director TitleAgeSince
Director/Board Member 64 2013-06-27
Director/Board Member 50 2020-04-02
Chairman 72 2024-01-29
Date Insider Type Main position Quantity % Market Cap. Importance
9/22/26 Tax

Chief Executive Officer

-1,456 0.0033%
9/14/26 Free

General Counsel

15,272 0.0349%
9/14/26 Free

President Multiomics

15,272 0.0349%
Change 5-day change 1-year change 3-year change Capi.($)
+3.97%+10.53%+29.54%-12.38% 1.78B
+0.65%-3.36%+36.98%+60.50% 64.14B
+0.95%+2.66%+12.22%+83.86% 55.53B
+0.92%+0.96%+12.13%+103.60% 53.03B
+2.76%+0.87%+27.92%+55.07% 45.99B
+2.00%-3.39%+17.83%+119.04% 42.45B
+1.34%-2.86%+224.43%+914.08% 40.45B
+0.64%-3.95%+11.15%+45.57% 32.25B
-2.09%+44.24%+105.92%+92.27% 34.47B
-2.72%-0.44%+23.18%-10.77% 24.23B
Average +0.84%+4.73%+50.13%+145.08% 39.43B
Weighted average by Cap. +0.76%+3.52%+49.30%+159.66%

Financials

2026 *2027 *
Net sales 615M 552M 510M 462M 863M 58.55B 873M 6.1B 2.43B 30.64B 2.31B 2.26B 97.27B 639M 574M 530M 480M 897M 60.88B 908M 6.34B 2.53B 31.86B 2.4B 2.35B 101B
Net income -166M -148M -137M -124M -232M -15.76B -235M -1.64B -654M -8.25B -621M -608M -26.18B 9.23M 8.28M 7.66M 6.94M 12.96M 879M 13.12M 91.57M 36.47M 460M 34.65M 33.92M 1.46B
Net Debt - -
Projected Income Statement - Annual - Azenta, Inc.
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
26-10-28 US$40.63 +3.97% 900,737
26-10-27 US$39.08 +5.14% 1,676,550
26-10-26 US$37.17 +1.84% 657,939
26-10-23 US$36.50 +1.36% 478,678
26-10-22 US$36.01 -2.04% 813,313
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Azenta, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
40.63USD
Average target price
37.80USD
Spread / Average Target
-6.97%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Azenta, Inc.
  1. Stock Market
  2. Stocks
  3. AZTA Stock